This paper considers the confirmation of diagnosis, made initially from histological analysis of tumour tissue, of neuroendocrine tumour disease, using elevated secretory products in the blood. These include hormones, peptides, neurotransmitters and packaging proteins of secretory vesicles such as chromogranin A.